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Abstract
Background: In implant dentistry, bone substitute materials and barrier membranes are used in different treat-
ments including guided bone regeneration (GBR), socket preservation, alveolar ridge augmentation, maxillary 
sinus elevation, and filling bony defects around the inserted dental implant. One of the most important factors 
in prognosis of treatments using these materials is the growth of new blood vessels in applied areas. Present re-
view was performed to evaluate the effect of the bone-grafting and barrier membrane materials on angiogenesis 
events. 
Material and Methods: An electronic search was performed in PubMed, MEDLINE, and EMBASE databases via 
OVID using the keywords mentioned in the PubMed and MeSH headings regarding the role of angiogenesis in 
implant dentistry from January 2000-April 2014.  
Results: Of the 5,622 articles identified in our initial search results, only 33 met the inclusion criteria set for this 
review. Among bone substitute materials the autogenous bone-grafts, and among the barrier membranes the col-
lagenous membranes, had the highest angiogenic potentials. Other bone-grafting materials or membranes were 
mostly used with pro-angiogenic factors to enhance their angiogenic properties.
Conclusions: Angiogenesis is one of the key factors, which plays a critical role in success rate of GBR technique 
and is seriously considered in manufacturing bone-grafting and barrier membrane materials. However, there is 
still lack of clinical and in-vivo studies addressing the effect of angiogenesis in treatments using bone-grafting 
and barrier membrane materials. 
Key words: Angiogenesis, bone-grafting materials, GBR, ridge augmentation, sinus elevation, socket preserva-
tion.
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Introduction 
In the field of implant dentistry, bone-grafting and bar-
rier membrane materials can be used in different situ-
ation such as the socket preservation (1), alveolar ridge 
horizontal and/or vertical augmentation, maxillary si-
nus elevation, and filling the bony defects or exposed 
threads of implants in order to maintain the required 
space and provide the necessary time period for migra-
tion of regenerative cells to the applied sites (2). The 
main purpose of using these materials is to prohibit the 
migration of epithelial or fibroblast cells, and only per-
mit the migration of osteogenic cells into the applied 
site to regenerate the hard tissue in deficient areas (3,4). 
The most important principles for increasing the suc-
cess rate of treatments using these materials is the space 
maintaining, exclusion of epithelial and connective tis-
sue cells migration to the site, the stabilization of blood 
clot, and the tight closure of surgical site (5).
Besides these primary surgical principles, blood supply 
is another crucial factor that provide the required nutri-
tional elements, oxygen, immune system cells, mesen-
chymal stem cells, and growth factors (6-9). This blood 
supply is accomplished through angiogenesis, which 
includes the formation of new blood vessels from pre-
existing vascular network present in adjacent soft and 
supraperiosteal tissues (6,10,11). It was shown that the 
formation of blood vessels through angiogenesis pro-
cess is an undeniable factor in regenerative procedures 
such as dentin-pulp complex and dental pulp regenera-
tion (12).
In bone regenerations, angiogenesis plays a central role 
by providing the functional connection between the 
grafting-material and surrounding host tissues. The 
well established and mature vascular networks can as-
sist and accelerate the regenerative processes. In order 
to promote angiogenesis events, it is suggested to decor-
ticate the surrounding bone to assist with the connection 
between blood vessels in the bone marrow of adjacent 
bone and bone substitute materials (6,13). 
According to the facts, the present review intended to 
discuss the angiogenic potential of bone-grafting and 
barrier membrane materials used in bone regenera-
tion procedures. It was hypothesis that whether bone-
grafting and barrier membrane materials promote the 
angiogenesis event in regeneration and what are the cur-
rent methods for enhancing the pro-angiogenic effect of 
these materials.
Material and Methods 
1- The Review Purpose:
Present study was performed to evaluate the effect of 
different bone-grafting and barrier membrane materials 
on angiogenesis events during bone regeneration pro-
cesses in the alveolar bone.  The main aspects pursued 
in this review include: 1) the angiogenic potential of di-
fferent bone-grafting materials including autogenous, 
allogenic, xenogeneic, and alloplastic bone materials; 2) 
the mechanism of action by which these materials can 
present pro- or anti-angiogenic effects; 3) which one of 
the bone materials has the highest pro-angiogenic po-
tential; 4) what are the current approaches to enhance 
the pro-angiogenic effects of these materials; 5) The 
angiogenic potential of different barrier membranes 
including collagenous, polymeric, e-PTFE, d-PTFE, 
titanium-reinforced, and titanium Mesh membranes; 6) 
which one of these barrier membranes has the highest 
angiogenic property; and 7) what are the current appro-
aches to enhance the pro-angiogenic effects of  resorba-
ble or non-resorbable membranes materials.   
2- Inclusion and Exclusion Criteria:
The inclusion criteria were: 1) studies published in 
English; 2) studies accepted and published between 
January 2000-April 2014; 3) the scientific in-vitro, in-
vivo, or ex-vivo articles, reviews, systematic reviews, 
case reports with controlled study design; 4) studies 
that had evaluated the effect of autogenous, allogenic, 
xenogeneic, or alloplastic bone-grafting materials on 
angiogenesis processes in the applied area; 5) studies 
that had utilized different pro-angiogenic substances in 
combination with these bone materials; 6) studies that 
had evaluated the impact of collagenous, polymeric, e-
PTFE, d-PTFE, titanium-reinforced, or titanium Mesh 
membranes on angiogenesis processes in the applied 
area; and 7) studies that have used different pro-angio-
genic agents to enhance angiogenic potential of these 
membranes. The exclusion criteria were: 1) studies that 
were published before January 2000 or after April 2014; 
2) studies that had not evaluated the angiogenic poten-
tials of the bone-grafting or barrier membrane materials 
in GBR procedures.
3- Search Methodology: 
The searching methodology included electronic sear-
ches performed in the PubMed, MEDLINE, and EM-
BASE databases via OVID using keywords mentioned 
in the PubMed and MeSH headings including the effects 
of bone substitute and barrier membranes materials on 
angiogenesis events occurring in surgical sites after in-
sertion of the dental implant.  
4- Search Strategy:      
In the electronic search of scientific papers in the Pub-
Med, MEDLINE, and EMBASE databases, the fo-
llowing keywords were used in combination with an-
giogenesis: “guided bone regeneration”, “autogenous 
bone graft”, “autogenous bone graft stem cells”, “auto-
genous bone graft osteoblast”, “autogenous bone graft 
osteoclast”, “autogenous bone graft endothelial cells”, 
“allogenic bone graft”, “freeze-dried bone allograft 
(FDBA)”, “demineralized freeze-dried bone allograft 
(DFDBA)”, “xenogeneic bone graft”, “alloplastic bone 
graft”, “resorbable membranes”, “collagenous membra-
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nes”, “polymeric membranes”, “non-resorbable mem-
branes”, “e-PTFE membranes”, “d-PTFE membranes”, 
“titanium-reinforced membranes”, and “titanium mesh 
membranes”.
Results 
Of the 2,691 articles identified in the initial search re-
sults, only 33 met the inclusion criteria set for this re-
view. These 33 studies were directly related to the effect 
of bone-grafting materials and barrier membrane ma-
terials on angiogenesis processes, and are presented in 
table 1 and 1 continue. The relevant full text articles and 
the reference lists of the related articles were evaluated 
to supplement the search as well. The assessment of the 
eligibility and finding related data were performed by 
two reviewers independently. A third reviewer was se-
lected for further discussion and final agreement on any 
conflict met in the mentioned processes.
Discussion
1 Effect of bone-grafting materials on angiogenesis
Bone-grafting or bone substitute materials are bio-ma-
terials, which are used to replace bone defects (14,15). In 
1993 Misch, Dietsh studied different types of bone-graft-
ing materials and based on their mode of action, they 
categorized them into three different types including au-
togenous, allograft, and alloplastic materials (16). Three 
kinds of mode or mechanism of action were introduced 
as osteogenic, osteoinductive, and osteoconductive. Os-
teogenic property is the characteristic of a bone-grafting 
material, which is capable of production and develop-
ment of new bone even in the absence of undifferentiated 
mesenchymal stem cells. The osteoinductivity is referred 
to the materials, which can induce the undifferentiated 
mesenchymal stem cells present in surrounding bone 
to differentiate into osteoblast cells and secret and form 
new bones (17). The last mechanism is the osteoconduc-
tivity, which is related to the materials that only provide 
an inert scaffold or matrix for growth and development 
of surrounding undifferentiated mesenchymal stem cells 
(6). Basically, autogenous grafting materials are osteo-
genic, osteoinductive, and osteoconductive. While al-
lografts have osteoinductivity and osteoconductivity, and 
the alloplasts and xenografts only have osteoconductivity 
(6,16). The application of these grafting materials mainly 
depends on the size of bone defect and the topography of 
applied area (16). In the following sections the angiogenic 
effects of autogenous, allograft, alloplast, and xenograft 
materials are overviewed. 
2.1- Autogenous bone materials  
These bone-grafting materials are provided in block or 
particulate forms from other locations in the body of the 
same individual who is subjected to dental implant sur-
gery. These donor sites can be intraoral such as ramus, 
mandibular symphysis, maxillary tuberosity, and tori 
or exostoses. The extraoral areas are mainly the tibial 
plateau or iliac crest (6). Autogenous materials mostly 
used for larger bony defects, where three or more walls 
are lost (16). These materials are osteogenic, osteoin-
ductive, and osteoconductive, which are considered as 
material of choice for large bony reconstructions (16). 
The most important point about the autogenous bone 
materials is the similarity of these grafting materials to 
the applied bony area. In other word, whatever the de-
fected bone contains, the same substances can be found 
in the autogenous grafting material. These grafts have 
three components including: 1) a mature bony structure 
that serves as a physical matrix; 2) viable cells such as 
osteocytes, osteoclasts, bone marrow-derived mesen-
chymal stem cells (BM-MSCs), and also endothelial 
cells that might be neglected among these cells; and 3) 
growth factors and cytokines necessary for hard tissue 
regeneration (6). 
The bony structure of autografts can be either cortical, 
trabecular (cancellous), or corticotrabecular bone. Corti-
cal type grafts have more condensed structure with higher 
levels of growth factors such as bone morphogenic pro-
teins (BMP), while the trabecular types have more viable 
cells (18). The physical matrix of autogenous grafts has 
lesser effects on angiogenesis processes compared to the 
cellular and growth factor components. Regarding this 
issue, authors indicated that cortical bone grafts com-
pared to the cancellous type grafts have more resistance 
against the penetration of the newly formed vessels from 
the recipient bed into the graft material (19-21). 
The second component of autogenous grafts is the viable 
cells inside the graft material. Among these cells, the 
most important ones are the BM-MSCs, which provide 
osteogenicity through differentiation into bone progeni-
tor cells (22). These cells are capable of self-renewal and 
differentiation into osteogenic cells (23). The angiogen-
ic effects of these cells include the differentiation into 
vascular endothelial and/or pericyte-like cells (24,25). 
The other pro-angiogenic effect is through secretion of 
vascular endothelial growth factor (VEGF) or fibroblast 
growth factor-2 (FGF-2) (26-28). Oswald et al. reported 
that BM-MSCs, in the presence of 2% fetal calf serum 
and 50 ng/ml VEGF, can express specific markers of 
endothelial cells such as KDR and FLT-1 (29) (Table 1 
and 1 continue).     
The other resident cells are the osteoblasts, osteocytes, 
and osteoclasts which have remarkable role in angio-
genesis events. Chim et al. showed that these cells 
can produce angiogenic factors such as VEGF, FGF-2, 
BMP-7, receptor activator of NF-κB ligand (RANKL), 
and epidermal growth factor (EGF)-like family mem-
bers (30). Prasadam et al. indicated that octeocytes 
can promote angiogenesis through the VEGF-MAPK-
dependent signaling pathways in endothelial cells (31). 
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Wang et al. demonstrated that the VEGF production due 
to the hypoxia-inducible factor alpha (HIF-1α) pathway 
can promote bone formation indirectly by its effect on 
angiogenesis (32) (Table 1 and 1 continue). 
Endothelial cells are the other viable cells present in au-
togenous grafts. Authors indicated that bone endothelial 
cells have specific characteristics such as responding to 
estrogen, PTH, and cytokines (33,34). It was reported 
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that endothelial cells might control the differentiation 
rate of human bone marrow stromal cells (HBMSC) to 
osteoblasts (35). Investigators showed that endothelial 
cells can recruit the bone progenitor cells, and main-
tain them in a standby status before their migration 
to required site, and promote their differentiation into 
functional osteoblasts after migration from blood ves-
sels (35). The hypoxia induced pro-angiogenic factors 
such as VEGF can promote the expression of BMP-2 in 
endothelial cells. These results indicate that endothelial 
cells are in close relationship with bone formation or re-
modeling, and osteogenic cells such as osteoblasts (36) 
(Tables 1 and 1 continue, 2).        
2.2- Allogenic bone materials   
Generally the allogenic grafting materials are tissues 
derived from one individual and used as graft in another 
individual with different genetic traits. These materials 
are mostly considered to be osetoinductive and osteo-
conductive and do not express any osteogenic charac-
teristic, as autogenous bone grafts do (6). In order to 
eliminate the risk of cross contamination, two methods 
of freeze-drying and the Tutoplast® processing are uti-
lized to prepare allogenic bone grafts (37,38). The ma-
terials provided by freeze-drying technique include the 
demineralized freeze-dried bone allograft (DFDBA), 
which is osteoinductive and osteoconductive with fast-
er resorption rate; and the freeze-dried bone allograft 
(FDBA) that is osteoconductive with slower resorption 
rate (39). 
Larsen et al. reported that the neoangiogenesis at a re-
cipient site is critical for survival of vascularized allo-
genic bone grafts (Fig. 1). These authors evaluated the 
effects of VEGF, FGF-2, and the combination of these 
pro-angiogenic factors as an additive to allogenic bone 
materials, on the angiogenesis events occurring at graf-
ting site (40). They showed that FGF-2 had superior pro-
angiogenic effects in neoangiogenesis process at the re-
cipient site compared with VEGF (40). Moreira et al. in-
dicated that onlay grafts, which included autogenous and 
allogenic bone grafts in combination with platelet-rich 
plasma (PRP) as a modifier, promoted the angiogenesis 
and osteogenesis events in rabbit mandibles (41) (Table 1 
and 1 continue). 
Angiogenesis plays a significant role in osteoblast di-
fferentiation and bone matrix formation at grafted si-
tes (41). Nevins, Reynolds showed that platelet derived 
growth factor-BB (PDGF-BB) in combination with allo-
graft bone materials can be used for bone regeneration 
at implant sites (42). It was indicated that the PDGF-BB, 
which is a pro-angiogenic factor, with FDBA or DFD-
BA as a scaffold, can be utilized for alveolar bone aug-
mentation (42). Similar results were reported by Rosen 
et al. that showed in a retrospective case series report, 
of the effective combination of FDBA and PDGF-BB in 
major periodontal intraosseos defects (43). Boëck-Neto 
et al. evaluated the VEGF expression and microvessel 
density (MVD) after maxillary sinus augmentation 
with different allograft, alloplastic grafting materials 
(44). It was indicated that DFDBA and polymeric grafts 
induced the lowest level of VEGF expression and MVD, 
while the hydroxyapatite (HA) and calcium phosphate 
(CP) showed the highest values (44) (Tables 1 and 1 con-
tinue, 2). 
The combination of other pro-angiogenic factors such 
as BMPs, angiopoietins, matrix metalloproteinase 
(MMP), or stem cell factors (SCF) with allogenic grafts 
can be taken into consideration in future studies.
2.3- Xenogeneic and alloplastic bone materials  
Xenogeneic bone substitute materials are grafting ma-
terials obtained from other non-human species such as 
bovine. These substances are natural HA or anorganic 
bone matrix (ABM), which are obtained from the natu-
ral bone of bovine or other animal sources (6). The other 
grafting materials are the alloplastic substances, which 
are synthetic graft materials and include bioactive glass 
polymers, calcium carbonate, calcium sulfate, and syn-
thetic ceramic materials like tricalcium phosphate (TCP) 
and HA (6). Both xenogeneic and alloplastic materials 
are considered as osteoconductive substances (Fig. 1), 
which only provide a physical matrix for recipient cells 
to infiltrate into the graft and form the new hard tissue 
(16).  
Degidi et al. showed that a xenogeneic bone substitute 
material could significantly increase the MVD after six 
months. This grafting material could also induce VEGF 
expression when is used for sinus augmentation (45) 
(Tables 1 and 1 continue, 2).  
Fig. 1. The angiogenic effects of bone-grafting materials in bone 
regenerative procedure in schematic socket preservation illustration. 
Upper figure: the procedure of socket preservation using bone sub-
stitute material; Middle figure: presents a schematic figure of autog-
enous bone material including valuable cellular components such as 
BM-MSCs, osteocytes, and endothelial cells; Bottom figure: pres-
ents a schematic figure of allograft, xenograft, or allopalastic materi-
als, which only includes a matrix and incorporated growth factors 
(pink spots).
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As previously mentioned, Boëck-Neto et al. showed that 
the alloplastic ceramic materials like HA and calcium 
phosphate induce the highest amount of VEGF expres-
sion and (MVD) in maxillary sinus lifting surgery com-
pared with DFDBA and other alloplastic materials such 
as polymers (44). Canuto et al. indicated that nanocrys-
talline hydroxyapatite can promote the osteogenesis and 
angiogenesis by increasing the expression of BMP-4, 
BMP-7, and VEGF (46). Laschke et al. suggested that 
injectable nanocrystalline HA bone grafting materials 
such as Ostim due to their enhancing effect on micro-
vessel density and pro-angiogenic property, can be used 
for guided vascularization procedures (47) (Tables 1 and 
1 continue, 2). Pezzatini et al. demonstrated that HA 
nanocrystals can enhance angiogenesis by inducing the 
migration of endothelial cells and increasing the secre-
tion of matrix metalloproteinase-2 (MMP-2), activation 
of focal adhesion kinase (FAK), endothelial nitric oxide 
synthase (eNOS), and FGF-2 expression (48). In another 
study, Pezzatini et al. indicated that HA nanocrystals are 
effective on viability of endothelial cells of microvessel 
by inducing these cells to keep their healthy status and 
functional properties (49). Nakamura et al. reported that 
polarized HA present on silk fibroin scaffolds can posi-
tively affect endothelial cells migration and morphoge-
nesis, which results in promotion of angiogenesis events 
(50). Wu et al. demonstrated that nano-hydroxyapatite/
collagen/PLA (nHAC/PLA) can be used as bone substi-
tute material in new bone formation in segmental bone 
defects, due to its enhancing effect on angiogenesis and 
osteogenesis processes (51). 
Castaño et al. indicated that silicon-based calcium 
phosphate glasses (Bioglasses), due to their calcium ion 
release, can play a significant role in promotion of an-
giogenesis events (52). 
Smiler et al. used bone marrow aspirate including adult 
stem cells in combination with xenogeneic and alloplas-
tic scaffold in bone regeneration. These authors showed 
that these combinations can promote the proliferation, 
differenation, and maturation of stem cells and enhance 
the angiogenesis events (53). 
2.4- Effect of barrier membranes on angiogenesis 
In 1988, Dahlin et al. proposed the GBR procedure pro-
tocol, which included the surgical placement of a bar-
rier membrane on the subjected bony area to seal and 
provide the required space for bone regeneration (54). 
This study apparently showed the importance of using 
barrier membranes and their functional role in bone re-
generative procedures. The most important purpose for 
using barrier membranes is to create a space on defect-
ed bone in order to only permit the bone progenitor cells 
to migrate into this space, and prevent the in-growth of 
soft tissue cells into the defective area (54).
Barrier membranes are basically divided into two cat-
egories of resorbable and non-resorbable membranes. 
In the following sections the anigogenic properties of 
these membranes are overviewed.    
2.5- Resorbable membranes
Resorbable membranes are barrier membranes, which 
after a short time are resorbed by hydrolysis or catabolic 
reactions, and do not need to be removed from the graft-
ed site (55). However, these membranes, due to the fast 
biodegradation, might not be useful for regeneration 
procedures that require the physical space maintenance 
for more than one month (56).  Resorbable, membranes 
are categorized under two main groups of collagenous 
and polymeric membranes.
2.6- Collagenous membranes
Collagenous membranes are provided from type I or 
combination of type I and III collagens, which is ob-
tained from pericardium, skin, or tendons of human, 
procine, or bovine (57). Collagen membranes are con-
sidered as one of the ideal membranes for regenerative 
procedures due to their superior biocompatibility and 
bioactivities such as direct effect on bone formation 
(58), and chemotactic effects on periodontal ligament 
(PDL) or gingival fibroblasts (59,60).    
Gunda et al. indicated that collagen has a component 
known as non-collagenous domains (NC1), which im-
poses anti-angiogenic effects on surrounding tissues 
(61). Shen et al. reported that prolyl hydroxylase enzyme 
(PHD) is a key enzyme with central role in degradation 
of hypoxia inducible factor alpha (HIF-1α), which is an 
angiogenic initiating factor in tissue development, re-
generations, and reparations (62). These authors showed 
that PHD inhibitors such as L-MIM and DMOG can ef-
fectively activate HIF-1α, which resulted in VEGF pro-
duction (62). 
Vargas et al. indicated that addition of 10 wt% nano-
sized (20-30 nm) bioactive glass particles (n-BG) to 
the bovine type I collagen can promote the angiogenic 
characteristics of collagenous composites, which are 
used in tissue engineering procedures (63). Simion et 
al. used the pro-angiogenic factor, recombinant human 
PDGF-BB, on resorbable collagen matrix and reported 
promising results in soft tissue regenerative procedures 
(64) (Tables 1 and 1 continue, 2). 
2.7- Polymeric membranes
Polymeric membranes are the second category of re-
sorbable membranes, which are synthetic membranes 
composed of polyglycolides (PGAs), polylactides 
(PLAs), polyesters, and co-polymers (65). One of the 
disadvantages of polymeric membranes compared to 
collagenous membranes is the provocation of host in-
flammatory responses, which is much higher in case of 
polymeric membranes (66). However, polymeric mem-
branes are mostly degraded by hydrolysis reaction that 
reduces the pH value and produces an acidic condition, 
which negatively impacts bone regeneration process 
(67). 
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Azzarello et al. indicated that polyglycolic acid (PGA) 
and PGA modified with poly(lactic-co-glycolic acid) 
(PLGA) compared with one-layer porcine small in-
testinal submucosa (SIS) or two-layer SIS, have lower 
pro-angiogenic effects (68). Perets et al. suggested that 
PLGA microspheres are capable of controlled release of 
pro-angiogenic factors such as FGF-2. By incorporat-
ing this angiogenic factor, the PLGA membrane pro-
moted the angiogenesis processes at grafted areas (69). 
Shah et al. showed that PDGF-BB as a pro-angiogenic 
factor can be coated on PLGA for adaptive release in 
bone regenerative procedures (70). Yonamine et al. re-
ported that the incorporation of VEGF165 on PLGA 
membranes can effectively promote bone regeneration 
procedures (71). Ellis, Chaudhuri demonstrated that the 
PLGA hollow fibermembrane can promote angiogen-
esis by providing the micro channels inside its structure 
that permit angiogenesis to occur in these channels (72) 
(Tables 1 and 1 continue, 2).
2.8- Non-resorbable membranes:
Non-resorbable membranes are other types of mem-
branes, which require the clinician to remove them 
after application at grafted areas. These membranes 
are mostly contaminated with bacteria and must be 
removed within 4-6 weeks after surgical application. 
Non-resorbable membranes include different types such 
as expanded polytetrafluoroethylene (e-PTFE), high-
density polytetrafluoroethylene (d-PTFE), titanium-re-
inforced PTFE, and titanium mesh membranes (73). In 
the following section the anigogenic properties of these 
membranes are discussed.
2.9- E-PTFE, d-PTFE, and titanium-reinforced PTFE 
membranes
E-PTFE membranes have become a standard membrane 
for GBR procedures since 1990s  (74-76). Becker et al. 
indicated that e-PTFE membranes can be successfully 
used for bone regeneration procedures around dental 
implants (76). The other type of PTFE membranes, is 
the d-PTFE membrane, which has higher density and 
smaller pore size (> 0.3 µm) compared to e-PTFE mem-
branes with larger pore sized (5-20 µm) (77,78). D-PT-
FE membranes beside their higher density, have another 
advantage over e-PTFE membranes, which is their use 
in situations that the primary soft closure is not pos-
sible. In bone regeneration procedure such as socket 
preservation or other conditions, which due to tissue 
tension the primary closure is not affordable, the d-PT-
FE membranes can be used safely (78). Titanium-rein-
forced PTFE membranes contain a titanium framework 
embedded in e-PTFE or d-PTFE membranes, which en-
able them to be shaped easily and maintain their shape 
at surgical site. These membranes can be used in larger 
bony defects without rebounding or collapsing into the 
defective areas (6).
Song et al. used the e-PTFE membrane for regeneration 
of mandibular boney defects and evaluated its effects on 
angiogenesis processes at 2, 3, 4, and 8 weeks. These au-
thors noticed that the presence of e-PTFE non-resorbable 
membrane was effective in rebuilding the supraalveolar 
vascular network. However, it did not affect vascular 
anastomosing between new connective tissue and gingi-
val flap, while 2-4 weeks after removal of membranes the 
vascularization between the gingival flap and new con-
nective tissue became normal (79) (Table 1 and 1 con-
tinue). 
Kid, Williams showed that laminin-5-enriched extra-
cellular matrix can promote angiogenesis. These au-
thors used e-PTFE samples, which were modified with 
cell matrices that were enriched with laminin-5. They 
noticed that the density of blood vessels was increased 
significantly (80). In another study Kid et al. indicated 
that the modified e-PTFE with laminin-5 increased the 
endothelial cells adhesion and promoted neovascular-
ization process of the peri-implant tissues (81) (Table 1 
and 1 continue). 
2.10- Titanium Mesh membranes
Titanium mesh membranes are another type of non-
resorbable membranes, which have a great ability to 
maintain the space required for alveolar bone augmen-
tation. These membranes can perfectly withstand the 
pressure of overlying soft tissue and keep a large space 
for bone regeneration without collapsing (82). Funato et 
al. reported that rhPDGF-BB can be used in combina-
tion with titanium mesh membranes to enhance bone 
regenerative procedures in vertical ridge augmentation 
(83) (Table 1 and 1 continue).  
 
Conclusions
In this review the effects of bone-grafting and barrier 
membrane materials on the angiogenesis processes at 
recipient sites were overviewed. According to the re-
viewed studies the following conclusions were drawn: 
Autogenous grafting materials have the highest poten-
tial for inducing angiogenesis events at the recipient 
site. The angiogenic properties of these materials are 
closely related to the viable cells such as BM-MSCs, os-
teocytes, and endothelial cells.  
The angiogenic properties of allogenic bone materials 
are lower than other grafting bone substitutes. The ad-
dition of different pro-angiogenic factors such as VEGF, 
FGF-2, and PDGF can be promising in increasing the 
angiogenic activity of these materials. 
Among the xenogeneic and alloplastic bone materials, 
the HA and calcium phosphate have the highest pro-an-
giogenic effects. The modifications such as nano-sized 
HA crystals or the combination of calcium phosphate 
and Bioactive glass might enhance the pro-angiogenic 
activity in grafted areas.
Resorbable collagenous membranes had pro-angiogenic 
effects due to release of prolyl hydroxylase inhibitors 
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(L-MIM and DMGO), while the NC1 component in 
these membranes act as an anti-angiogenic agent. The 
recent trend includes the enrichment of collagenous 
membranes and scaffolds with PDGF-BB or nano-sized 
bioactive glass to enhance their angiogenic properties. 
The polymeric membranes do not have any remarkable 
inherent pro-angiogenic effects and are mostly used as 
scaffolds for delivering and controlled release of pro-
angiogenic factors. 
The angiogenic properties of e-PTFE, d-PTFE, titani-
um-reinforced PTFE, and titanium mesh membranes 
have not been well-discussed in the literature. However, 
these non-resorbable membranes might have some an-
giogenic potential, but most of the pro-angiogenic ef-
fects of these membranes are related to the incorporated 
pro-angiogenic agents, which are used to enhance the 
angiogenic activity.
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